Mostrar el registro sencillo del ítem

dc.contributor.authorSalluh J.I.F
dc.contributor.authorPóvoa P
dc.contributor.authorBeane A
dc.contributor.authorKalil A
dc.contributor.authorSendagire C
dc.contributor.authorSweeney D.A
dc.contributor.authorPilcher D
dc.contributor.authorPolverino E
dc.contributor.authorTacconelli E
dc.contributor.authorEstenssoro E
dc.contributor.authorFrat J.-P
dc.date.accessioned2024-11-01T14:34:43Z
dc.date.available2024-11-01T14:34:43Z
dc.date.issued2024
dc.identifier.issn3424642
dc.identifier.otherhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85189144424&doi=10.1007%2fs00134-024-07381-z&partnerID=40&md5=c8f3243587a2d31f487e38026f37442b
dc.identifier.urihttp://hdl.handle.net/10818/62203
dc.description.abstractSevere community-acquired pneumonia (sCAP) remains one of the leading causes of admission to the intensive care unit, thus consuming a large share of resources and is associated with high mortality rates worldwide. The evidence generated by clinical studies in the last decade was translated into recommendations according to the first published guidelines focusing on severe community-acquired pneumonia. Despite the advances proposed by the present guidelines, several challenges preclude the prompt implementation of these diagnostic and therapeutic measures. The present article discusses the challenges for the broad implementation of the sCAP guidelines and proposes solutions when applicable. © Springer-Verlag GmbH Germany, part of Springer Nature 2024.en
dc.formatapplication/pdfes_CO
dc.language.isoenges_CO
dc.publisherIntensive Care Medicinees_CO
dc.relation.ispartofseriesIntensive Care Medicine Vol. 50 N° 4
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.sourceUniversidad de La Sabanaes_CO
dc.sourceIntellectum Repositorio Universidad de La Sabanaes_CO
dc.subject.otherAntibiotic agenten
dc.subject.otherAntivirus agenten
dc.subject.otherCorticosteroiden
dc.subject.otherMacrolideen
dc.subject.otherProcalcitoninen
dc.subject.otherAntibiotic therapyen
dc.subject.otherAspiration pneumoniaen
dc.subject.otherCommunity acquired pneumoniaen
dc.titleChallenges for a broad international implementation of the current severe community-acquired pneumonia guidelinesen
dc.typejournal articlees_CO
dc.type.hasVersionpublishedVersiones_CO
dc.rights.accessRightsopenAccesses_CO
dc.identifier.doi10.1007/s00134-024-07381-z


Ficheros en el ítem

FicherosTamañoFormatoVer

No hay ficheros asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivatives 4.0 InternationalExcepto si se señala otra cosa, la licencia del ítem se describe como Attribution-NonCommercial-NoDerivatives 4.0 International